JCM Figure table search 04
Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Other Versions of this Article:
JCM.01447-06v1
44/11/4197    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hardick, A.
Right arrow Articles by Gaydos, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hardick, A.
Right arrow Articles by Gaydos, C.

 Previous Article  |  Next Article 

Journal of Clinical Microbiology, November 2006, p. 4197-4199, Vol. 44, No. 11
0095-1137/06/$08.00+0     doi:10.1128/JCM.01447-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.

Comparison between the Gen-Probe Transcription-Mediated Amplification Trichomonas vaginalis Research Assay and Real-Time PCR for Trichomonas vaginalis Detection Using a Roche LightCycler Instrument with Female Self-Obtained Vaginal Swab Samples and Male Urine Samples{triangledown}

Andrew Hardick, Justin Hardick, Billie Jo Wood, and Charlotte Gaydos*

Division of Infectious Diseases, Johns Hopkins University, School of Medicine, Baltimore, Maryland

Received 12 July 2006/ Accepted 21 August 2006

This study compared two assays for Trichomonas vaginalis detection, Gen-Probe's transcription-mediated amplification (TMA) assay for Trichomonas vaginalis and BTUB FRET PCR, using self-obtained clinical samples from 611 patients. Infection status was defined as two positive results by two different tests. The initial TMA assay sensitivity was 96.7%; specificity was 97.5%. The TMA assay was comparable to BTUB FRET PCR.

* Corresponding author. Mailing address: Division of Infectious Diseases, School of Medicine, Johns Hopkins University, 1159 Ross Building, 720 Rutland Ave., Baltimore, MD 21015. Phone: (410) 614-0932. Fax: (410) 614-9775. E-mail: cgaydos{at}jhmi.edu.

{triangledown} Published ahead of print on 30 August 2006.

Journal of Clinical Microbiology, November 2006, p. 4197-4199, Vol. 44, No. 11
0095-1137/06/$08.00+0     doi:10.1128/JCM.01447-06
Copyright © 2006, American Society for Microbiology. All Rights Reserved.



This article has been cited by other articles:



Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Antimicrob. Agents Chemother. Clin. Microbiol. Rev.
Clin. Vaccine Immunol. ALL ASM JOURNALS

Copyright © 2006 by the American Society for Microbiology. All rights reserved.